KCA
IRON icon

KVP Capital Advisors’s Disc Medicine IRON Stock Holding History

KVP Capital Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.26M Hold
58,250
– – 3.13% 11
2026
Q1 		$3.72M Hold
58,250
– – 2.78% 13
2025
Q4 		$4.63M Buy
+58,250
New +$4.92M 4.48% 9

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KVP Capital Advisors's IRON Position: Q2 2026 in Review

KVP Capital Advisors held its Disc Medicine (IRON) position steady in Q2 2026 at 58,250 shares worth $4.26M. The position accounts for 3.13% of the portfolio, ranked #11.

KVP Capital Advisors first reported a position in IRON in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.63M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • KVP Capital Advisors held 58,250 shares of Disc Medicine worth $4.26M as of Q2 2026.
  • KVP Capital Advisors left its Disc Medicine share count unchanged in Q2 2026.
  • Disc Medicine made up 3.13% of KVP Capital Advisors's portfolio in Q2 2026, its #11 holding.
  • KVP Capital Advisors first reported a position in Disc Medicine in Q4 2025 and has held it in 3 quarters since.
  • KVP Capital Advisors's Disc Medicine position peaked at $4.63M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on KVP Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.